Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: J Urol. 2020 Jan 7;203(6):1117–1121. doi: 10.1097/JU.0000000000000742

Table 2.

Triggers for treatment

Values represent frequency (percentage).

Reason N=64
Patient Preference 19 (30%)
Biopsy Volume Progression 15 (23%)
Biopsy Grade Progression 14 (22%)
MRI Result 9 (14%)
Change in PSA Value or Digital Rectal Examination 4 (6%)
Prolaris Result (tissue-based biomarker) 3 (5%)

Abbreviation: MRI=magnetic resonance imaging, PSA=prostate-specific antigen